JP2023535620A5 - - Google Patents

Info

Publication number
JP2023535620A5
JP2023535620A5 JP2023505948A JP2023505948A JP2023535620A5 JP 2023535620 A5 JP2023535620 A5 JP 2023535620A5 JP 2023505948 A JP2023505948 A JP 2023505948A JP 2023505948 A JP2023505948 A JP 2023505948A JP 2023535620 A5 JP2023535620 A5 JP 2023535620A5
Authority
JP
Japan
Prior art keywords
amino acid
sequence
seq
acid sequence
capsid protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023505948A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535620A (ja
JP7841821B2 (ja
Filing date
Publication date
Priority claimed from GBGB2011871.7A external-priority patent/GB202011871D0/en
Application filed filed Critical
Publication of JP2023535620A publication Critical patent/JP2023535620A/ja
Publication of JP2023535620A5 publication Critical patent/JP2023535620A5/ja
Application granted granted Critical
Publication of JP7841821B2 publication Critical patent/JP7841821B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023505948A 2020-07-30 2021-07-30 組成物および方法 Active JP7841821B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2011871.7 2020-07-30
GBGB2011871.7A GB202011871D0 (en) 2020-07-30 2020-07-30 Composition and method
PCT/GB2021/051985 WO2022023773A1 (en) 2020-07-30 2021-07-30 Composition and method

Publications (3)

Publication Number Publication Date
JP2023535620A JP2023535620A (ja) 2023-08-18
JP2023535620A5 true JP2023535620A5 (cg-RX-API-DMAC7.html) 2024-08-07
JP7841821B2 JP7841821B2 (ja) 2026-04-07

Family

ID=72425275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505948A Active JP7841821B2 (ja) 2020-07-30 2021-07-30 組成物および方法

Country Status (10)

Country Link
US (1) US20230295237A1 (cg-RX-API-DMAC7.html)
EP (1) EP4188940A1 (cg-RX-API-DMAC7.html)
JP (1) JP7841821B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230041820A (cg-RX-API-DMAC7.html)
CN (1) CN116406427A (cg-RX-API-DMAC7.html)
AU (1) AU2021319154A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023001611A2 (cg-RX-API-DMAC7.html)
CA (1) CA3190289A1 (cg-RX-API-DMAC7.html)
GB (1) GB202011871D0 (cg-RX-API-DMAC7.html)
WO (1) WO2022023773A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202022003132U1 (de) 2021-04-01 2025-02-17 The Regents Of The University Of California Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten
CN119095867A (zh) * 2022-03-24 2024-12-06 卡西达公司 具有优选的脑富集的所选aav组合物
CA3254570A1 (en) * 2022-03-24 2023-09-28 Capsida, Inc. ADENE-ASSOCIATED VIRUS COMPOSITIONS WITH INCREASED CARDIAC ENRICHEMENT
AU2023267474A1 (en) * 2022-05-13 2024-12-05 Children's Medical Research Institute Adeno-associated virus capsids
EP4526325A4 (en) * 2022-05-17 2026-08-05 Capsida Inc SELECTED ADENE-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED LEVELS OF CEREBRAL, SPINAL CORD AND/OR CARDIAC EXPRESSION
US20260108560A1 (en) * 2022-07-13 2026-04-23 The Regents Of The University Of California Transplanting stem cell-derived microglia to treat leukodystrophies
KR20260003703A (ko) * 2023-04-07 2026-01-07 4디 몰레큘러 테라퓨틱스 아이엔씨. 보체 장애의 치료를 위한 aav 변이체
CN118480098B (zh) * 2023-09-20 2024-11-08 广州派真生物技术有限公司 腺相关病毒突变体及其应用
CN117660370B (zh) * 2023-11-08 2025-03-21 中国人民解放军空军军医大学 一种重组腺相关病毒、抗炎药物及其在脓毒性脑病治疗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
AU2016366549B2 (en) 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
US11512327B2 (en) 2017-08-03 2022-11-29 Voyager Therapeutics, Inc. Compositions and methods for delivery of AAV
EP3830107A2 (en) * 2018-08-03 2021-06-09 Voyager Therapeutics, Inc. Aav variants with enhanced tropism

Similar Documents

Publication Publication Date Title
JP7374119B2 (ja) 減少した肝臓向性を有するAAV9とAAVrh74とのハイブリッド組換えアデノ随伴ウイルス血清型
JP2022508182A5 (cg-RX-API-DMAC7.html)
JP6363958B2 (ja) Aav変異体
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2023504314A5 (cg-RX-API-DMAC7.html)
JP2023544683A5 (cg-RX-API-DMAC7.html)
JP2020048571A5 (cg-RX-API-DMAC7.html)
JP2019116492A5 (cg-RX-API-DMAC7.html)
JP2022500066A5 (cg-RX-API-DMAC7.html)
JP2022529631A5 (cg-RX-API-DMAC7.html)
JP2022535749A5 (cg-RX-API-DMAC7.html)
US20230049066A1 (en) Novel aav3b variants that target human hepatocytes in the liver of humanized mice
JP2018522529A5 (cg-RX-API-DMAC7.html)
JP2022547197A5 (cg-RX-API-DMAC7.html)
JP2022523679A5 (cg-RX-API-DMAC7.html)
JP2020500541A5 (cg-RX-API-DMAC7.html)
JP2022523719A (ja) Aavキャプシドの転写依存性定方向進化を使用するための方法
CN101511373A (zh) 用于基因治疗的修饰的因子viii和因子ix基因和载体
JP2022541070A5 (cg-RX-API-DMAC7.html)
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
WO2020208032A1 (en) Hybrid promoters for muscle expression
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023524024A5 (cg-RX-API-DMAC7.html)
JP2025514489A5 (cg-RX-API-DMAC7.html)